Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy

Gut

Volumn 59, Issue 3, 2010, Pages 320-324

  Van Assche, G ^a   Thienpont, C ^a   D'Hoore, A ^a   Vermeire, S ^a   Demedts, I ^a   Bisschops, R ^a   Coremans, G ^a   Rutgeerts, P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; C REACTIVE PROTEIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; BALLOON DILATATION; CONTROLLED STUDY; CROHN DISEASE; DILATATION; DISEASE ACTIVITY; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OBSTRUCTION; PATIENT SAFETY; PERFORATION; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; BALLOON DILATATION; COLONOSCOPY; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; INTESTINAL PERFORATION; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 77749320430     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.180182     Document Type: Article

References (21)

1. Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumor necrosis factor-alpha interleukine-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with crohn's disease. Gut 1996;39:684-9.
2. Hassan C, Zullo A, Campo S, et al. New insights into the biological therapy of crohn's disease. Expert Opin Ther Pat 2005;15:409-19
3. McKaig BC, Hughes K, Tighe PJ, et al. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am J Physiol Cell Physiol 2002;282:172- 82.
4. Graham MF, Willey A, Adams J, et al. Interleukin 1 beta downregulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology 1996;110:344-50.
5. Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63.
6. Hassan C, Zullo A, De Francesco V, et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007;26:1457-64.
7. Sabaté JM, Villarejo J, Bouhnik Y, et al. Hydrostatic balloon dilatation of crohn's strictures. Aliment Pharmacol Ther 2003;18:409-13.
8. Ferlitsch A, Reinisch W, Puspok A, et al. Safety and efficacy of endoscopic balloon dilation for treatment of crohn's disease strictures. Endoscopy 2006;38:483-7.
9. Thomas-Gibson S, Brooker JC, Hayward CM, et al. Colonoscopic balloon dilatation of crohn's strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 2003;15:485-8.
10. Cockuyt H, Gevers AM, Coremans G, et al. Efficacy and safety of hydrostatis balloon dilatations of ileocolonic crohn's strictures: a prospective longterm analysis. Gut 1995;36:577-80.
11. Matsui T, Hatakeyama S, Ikeda K, et al. Long-term outcome of endoscopic balloon dilatation in obstructive gastroduodenal Crohn's disease. Endoscopy 1997;29:640-5.
12. Singh V, Draganov P, Valentine J. Efficacy and safety of endoscopic balloon dilatations of symptomatic upper an lower gastrointestinal Crohn's disease strictures. J Clin Gastroenterol 2005;39:284-90.
13. Ajlouni Y, Iser JH, Gibson PR. Endoscopic balloon dilatation of intestinal strictures in Crohn's disease: Save alternative to surgery. J Gastroenterol Hepatol 2007;22:486-90.
14. Dear KL, Hunter JO. Colonoscopic hydrostatic balloon dilatation of crohn's strictures. J Clin Gastroenterol 2001;33:315-18.
15. Nomura E, Takagi S, Kikuchi T, et al. Efficacy and safety of endoscopic balloon dilatation for Crohn's Strictures. Dis Colon Rectum 2006;49:S59-S67.
16. Brooker JC, Beckett CG, Saunders BP, et al. Long-acting steroid injection after endoscopic dilation of anastomotic Crohn's strictures may improve the outcome: a retrospective case series. Endoscopy 2003;35:333-7.
17. Rambour C, Verhamme M, Dhondt E, et al. Endoscopic treatment of stenosis in recurrent Crohn's disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc 1995;42:252-5.
18. Hoffmann JC, Heller F, Fais S, et al. Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications and effectiveness. Int J Colorectal Dis 2008;23:689-96.
19. Burke JP, Mulsow JJ, O'Keane C, et al. Fibrogenesis in Crohn's disease. Am. J Gastroenterol 2007;102:439-48.
20. East JE, Brooker JC, Rutter MD, et al. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures. Clin Gastroenterol Hepatol 2007;5:1065-9.
21. Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006;55:1561-7.